Navigation Links
Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc

The board of directors of Segetis, Inc has announced the appointment of James Stoppert as President and Chief Executive Officer of the company.

MINNEAPOLIS (Business Wire EON) September 3, 2008 -- Segetis is the first and only company to unlock the chemical "binary code" for developing a wide range of industrial chemicals and plastics that are ultimately derived from non-food agricultural and forestry sources. Backed by Khosla Ventures, Segetis is focused on developing a broad portfolio of bio-based materials made entirely or in a major part with use of proprietary renewable binary monomers.

Stoppert comes to Segetis from Cargill, where he led The Industrial BioProducts Business Unit focused on renewable routes to chemicals and plastics. Two of the opportunities developed, Elevance and BiOH, are now standalone businesses. Stoppert has more than 35 years of commercial experience in the chemicals industry. In 1997 he was appointed CEO of Cargill Dow LLC (now NatureWorks LLC), which led the green revolution in the chemical industry by producing plastics derived entirely from annually renewable resources like corn. Prior to Cargill Dow LLC, he held several positions with Dow Chemical, managing several major Dow Plastics businesses as well as major environmental issues for Dow's Global Plastics business.

"Jim brings a wealth of chemical industry experience to Segetis, he is also a pioneer in developing green chemicals from renewable resources," said Vinod Khosla, founder Khosla Ventures. "With Jim's addition Segetis has entered a new phase of growth that has a unique combination of powerful broad-impact technology and a strong management team."

"We have developed a broad platform of bio-based materials that enable the company to participate in numerous global applications and markets," said Sergey Selifonov, the inventor of the binary monomer technology, Segetis founder and Chief Scientific Officer. "Jim is a first class leader for helping us take the next step towards commercialization."

"The addition of Jim Stoppert as CEO signals that we are progressing from discovery to commercialization," added Olga Selifonova, co-founder of Segetis and Vice President of Corporate Development. "We are on the verge of producing breakthrough products that deliver the cost and performance required to compete with fossil-fuel–based materials."

About Segetis

Segetis is focused on commercializing a proprietary platform of binary monomers based on renewable feedstocks. As the first and only company to unlock the "binary code" of green chemistry, Segetis technology will deliver the cost and performance required to compete with fossil-fuel–based materials. Segetis strives to operate in a socially responsible manner as it pursues its mission of enabling industry to transform itself from dependence on fossil fuels to a more sustainable future. Segetis has been established in 2006 and began its accelerated growth in January of 2007 when the founders, Sergey Selifonov and Olga Selifonova, have secured Series A financing from Khosla Ventures.

For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
2. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
3. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
4. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
5. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
6. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
7. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
8. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
9. Ikaria Founding Scientist Named 2007 MacArthur Fellow
10. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
11. Abbott Named One of the Best Places to Launch a Career by BusinessWeek
Post Your Comments:
Related Image:
 Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc 
(Date:11/30/2015)... Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that ... its Board of Directors to replace Dr. Peter Johann ... experience as co-founder of Resverlogix, with expertise in the fields ... --> Dr. Wong remarked, "I am very excited ... standing expertise in epigenetics and the advanced stage of the ...
(Date:11/30/2015)... , November 30, 2015 TapImmune, ... the development of innovative peptide and gene-based immunotherapeutics and ... today announced it will be presenting at the 8 ... 1, 2015 at 2.30 PM PT. Dr. John ... Advisor will be giving the presentation and will join ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, and ... covers a wide range of applications such as, but not limited to, biotechnology, ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
Breaking Biology News(10 mins):